Naproxen is an NSAID that inhibits COX enzymes to reduce inflammation and pain, whilst Wegovy is a GLP-1 receptor agonist that regulates appetite and glucose metabolism through completely separate pathways
SGLT2 inhibitors may affect the tumor microenvironment by altering the composition of immune cells, cytokine profiles, and angiogenesis
Higher doses increase the risk of side effects such as adrenal suppression and pneumonia
The stability of phytochemicals present in GO, mainly allicin, was improved when biogenic nanoscale mesoporous silicon derived from the silicon-accumulator plant Tabasheer ( Bambuseae ) was used as a potential carrier as the antibacterial activity of this material was better than GO only control (Le et al., 2017)
Dual GLP-1/GIP receptor agonists that can cross the BBB show superior neuroprotective effects
[DOI] [PMC free article] [PubMed] [Google Scholar] 412.Courties, A